Celiac Disease in Children Clinical Trial
— GF-NOURISHOfficial title:
GF-NOURISH (Gluten Free Nutrition Optimization Through Ultra-processed Food Reduction and Improved Strategies for Health)
Verified date | May 2024 |
Source | Boston Children's Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The investigators propose the Gluten Free Nutrition Optimization through Ultra-processed food Reduction and Improved Strategies for Health (GF-NOURISH) study to demonstrate the feasibility and success of a nutritional education program focused on naturally occurring gluten-free foods and minimizing ultra-processed gluten-free foods. The investigators hypothesize that nutritional educational (GF-NOURISH) intervention will have multiple health benefits
Status | Not yet recruiting |
Enrollment | 120 |
Est. completion date | July 2026 |
Est. primary completion date | January 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 2 Years to 18 Years |
Eligibility | Inclusion Criteria: - Age 2-18 years of age with recent celiac disease diagnosis Exclusion Criteria: - Allergic to <3 of the top 8 food allergens - Co-morbid conditions treated with dietary modifications or that influence nail arsenic values |
Country | Name | City | State |
---|---|---|---|
United States | Boston Children's Hospital | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Boston Children's Hospital |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | To compare the effect of GFFG versus conventional GFD class on body composition, specifically fat free mass | While the gold standard measurement for body composition is dual energy X-ray absorptiometry (DEXA) or underwater weighing and air displacement plethysmography (BodPod), these techniques require special facilities that increase cost, are difficult to perform in outpatient settings. DEXA scans also involve radiation exposure. Therefore, the investigators will use bio-impedance spectroscopy analysis (BSA), which is a simple, noninvasive, reproducible, portable and convenient method to measure body composition.26 BSA utilizes body resistance and reactance to derive phase angle (PhA) and estimate the fat (FM) and non-fat (FFM) components of the body | Over 6 months | |
Secondary | To compare the effect of GFFG vs conventional GFD class on diet quality | Given that one of primary objectives of the GFFG is to decrease ultra-processed gluten-free foods (UPGFF), this aim focuses on assessing the impact of the nutrition education intervention on participant's recorded UPF consumption and diet quality. All participants will fill out a three-day food frequency record at study entry and six months of GFD. Food items will be classified by the NOVA system: the most used identification system for UPFs. Of the four leading food processing-based classification systems (NOVA, IARC(International Agency for Research on Cancer), IFIC(International Food Information Council) and UNC(University of North Carolina)), NOVA has been used in 95% of studies on consumption of highly processed foods and chronic health outcome published between 2015 and 2019 in children and adults. NOVA categorizes all the foods by level of food processing: i) unprocessed or minimally processed, (ii) processed culinary ingredients, (iii) processed foods and (iv) UPFs. | Over 6 months | |
Secondary | To compare the effect of GFFG versus conventional GFD on arsenic exposure | The outcome is nail arsenic level after six months on GFD. Toenails will be stored at room temperature and are stable as heavy metals naturally bind to keratin. Toenails will be cleaned to remove exogenous contamination, and then, acid digested. | Over 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04440501 -
Virtual Reality to Teach, Improve Outcomes, and Engage (VIRTUE): Virtual Reality to Improve Gluten-Free Diet Knowledge in Pediatric Celiac Disease
|
N/A | |
Enrolling by invitation |
NCT06179121 -
"Adding DNA-test for Screening of HLA-DQ2 and DQ8 to Improve Early Diagnosis of Celiac Disease"
|
||
Recruiting |
NCT06324539 -
Validation of a New Innovative Method for Specific Marker Detection in Celiac Disease
|
||
Completed |
NCT06359613 -
Efficacy Assessment of Gluten Free Cupcakes
|
N/A | |
Active, not recruiting |
NCT05548166 -
Development of CELIAC-Q KIDS: A Patient-Reported Outcome Measure for Pediatric Celiac Disease
|
||
Recruiting |
NCT04014660 -
Prevention av Autoimmunitet Med Laktobaciller
|
N/A | |
Not yet recruiting |
NCT04019223 -
Anti-Tissue Transglutaminase IgA Antibodies
|
||
Completed |
NCT03966625 -
Serological Identification of Celiac Disease in Kids
|
||
Not yet recruiting |
NCT03244254 -
Intestinal Fatty Acid-binding Protein (I-FABP) Levels in Pediatric Celiac Patients
|
N/A | |
Recruiting |
NCT05132725 -
Carbohydrate Counting and DASH Intervention Among Children With Diabetes and Celiac Disease.
|
N/A | |
Enrolling by invitation |
NCT05084937 -
Celiac Disease in Childhood-Adulthood Transition
|
N/A | |
Active, not recruiting |
NCT04593888 -
Gluten Reduction and Risk of Celiac Disease
|
N/A | |
Recruiting |
NCT06007898 -
Supporting Children and Young People to Live Well With Coeliac Disease
|
N/A | |
Recruiting |
NCT06364735 -
Entities and Variables Related to Catch-up Growth
|
||
Completed |
NCT04272983 -
Population Study of the Prevalence of Celiac Disease and Other Gluten-dependent Disorders in Children and Adolescents
|
||
Not yet recruiting |
NCT06149507 -
Effect of Acetaminophen Versus Ibuprofen in Treating Recurrent Apthous Ulcers in Pediatric Celiac Disease
|
Phase 4 | |
Completed |
NCT04240340 -
Experiences of Disclosure in Adolescents With Coeliac Disease
|
||
Completed |
NCT03176095 -
Celiac Disease Prevention With Probiotics
|
N/A | |
Active, not recruiting |
NCT06038344 -
Influence of a Gluten Free Food Guide on Diet Quality and Adherence to the GFD in Youth With Celiac Disease
|
N/A | |
Completed |
NCT04533776 -
Support for Adolescents With Celiac Disease
|
N/A |